Journal Report

Pulmonary Pharmacology and Therapeutics

Download PDF
Journal Information
Journal Title
Pulmonary Pharmacology and Therapeutics
Publisher
Academic Press
ISSN
1094-5539
E-ISSN
1522-9629
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Tectochrysin alleviates idiopathic pulmonary fibrosis via inhibiting PI3K/AKT/mTOR signaling pathway by targeting PI3K p85
Mengying Li, Tingfang Xiao, Xuanyu Chen et al.
2026-12 Vol. 95 Pages 102455
DOI: 10.1016/j.pupt.2026.102455
Steroid-sparing strategies in respiratory diseases: efficacy and safety of current therapeutic options
Mateusz Gadzała, Aleksandra Paź, Dagmara Mirowska-Guzel
2026-12 Vol. 95 Pages 102451
DOI: 10.1016/j.pupt.2026.102451
TNF-α–mediated molecular switching links COPD to lung cancer: Integrated in silico and in vivo study of oxidative stress–driven disease transition
Riya Manna, Jagannath Das, Debraj Roy et al.
2026-12 Vol. 95 Pages 102441
DOI: 10.1016/j.pupt.2026.102441
Belumosudil improves experimental pulmonary fibrosis via the ROCK2/Smad3/CTGF pathway
Dexin Kong, Guanghua Zhang, Zhonghong Jiang et al.
2026-12 Vol. 95 Pages 102452
DOI: 10.1016/j.pupt.2026.102452
First-in-human safety and pharmacokinetic evaluation of seralutinib, an investigational inhaled tyrosine-protein kinase inhibitor for pulmonary hypertension
Jianke Li, Lawrence S. Zisman, Matt Cravets et al.
2026-12 Vol. 95 Pages 102453
DOI: 10.1016/j.pupt.2026.102453
Efficacy and safety of magnesium glycinate as add on therapy in hypomagnesemic asthma and chronic obstructive pulmonary disease patients: A randomised controlled study assessing inflammatory biomarkers
Maneesh Kumar Maddirevula, Muhasaparur G. Rajanandh, Boman Wesley
2026-12 Vol. 95 Pages 102440
DOI: 10.1016/j.pupt.2026.102440
Pharmacological enhancement of O-GlcNAcylation attenuates lung ischemia-reperfusion injury
Yang Jin, Yu Fu, Nan Zhang et al.
2026-12 Vol. 95 Pages 102456
DOI: 10.1016/j.pupt.2026.102456
Targeting pulmonary and arterial chemoreceptors via inhaled therapeutics: A novel pathway to blunt hypoxia-induced pulmonary hypertension?
Durlav Chowdhury, Surendra H. Bodakhe
2026-12 Vol. 95 Pages 102450
DOI: 10.1016/j.pupt.2026.102450
Cellular senescence and vascular ageing in pulmonary hypertension: Molecular mechanisms, therapeutic strategies, and translational endpoints
Yide Chen, Xiaolan Wang, Meng Gao et al.
2026-12 Vol. 95 Pages 102454
DOI: 10.1016/j.pupt.2026.102454
Methodological considerations on the effectiveness of biologics in asthma-COPD overlap
Tingfang Liu, Ye Jian
2026-9 Vol. 94 Pages 102439
DOI: 10.1016/j.pupt.2026.102439
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 9, 2026 14:47